Cited by 60Advanced Drug Delivery SystemsHydrogels: synthesis, properties, applicationsMicroencapsulation and Drying Processes

Dual growth factor delivery using biocompatible core–shell microcapsules for angiogenesis

Choi, Dong Hoon, Subbiah, Ramesh, Kim, Ik Hwan, Han, Dong Keun, Park, Kwideok·2013·Small

Abstract

An optimized electrodropping system produces homogeneous core-shell microcapsules (C-S MCs) by using poly(L-lactic-co-glycolic acid) (PLGA) and alginate. Fluorescence imaging clearly shows the C-S domain in the MC. For release control, the use of high-molecular-weight PLGA (HMW 270 000) restrains the initial burst release of protein compared to that of low-MW PLGA (LMW 40 000). Layer-by-layer (LBL) assembly of chitosan and alginate on MCs is also useful in controlling the release profile of biomolecules. LBL (7-layer) treatment is effective in suppressing the initial burst release of protein compared to no LBL (0-layer). The difference of cumulative albumin release between HMW (7-layer LBL) and LMW (0-layer LBL) PLGA is determined to be more than 40% on day 5. When dual angiogenic growth factors (GFs), such as platelet-derived GF (PDGF) and vascular endothelial GF (VEGF), are encapsulated separately in the core and shell domains, respectively, the VEGF release rate is much greater than that of PDGF, and the difference of the cumulative release percentage between the two GFs is about 30% on day 7 with LMW core PLGA and more than 45% with HMW core PLGA. As for the angiogenic potential of MC GFs with human umbilical vein endothelial cells (HUVECs), the fluorescence signal of CD31+ suggests that the angiogenic sprout of ECs is more active in MC-mediated GF delivery than conventional GF delivery, and this difference is significant, based on the number of capillary branches in the unit area. This study demonstrates that the fabrication of biocompatible C-S MCs is possible, and that the release control of biomolecules is adjustable. Furthermore, MC-mediated GFs remain in an active form and can upregulate the angiogenic activity of ECs.

Integrity signals

Registry

Crossref · 10.1002/smll.201300427

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Authors
Choi, D. H., Subbiah, R., Kim, I. H., Han, D. K., & Park, K.
Affiliations
  • Korea University (KR)
  • Korea Institute of Science and Technology (KR)
Corresponding author
  • Han, Dong Keun
  • Park, Kwideok
Venue
Small
Publisher
Wiley
Published
2013-04-15
Volume
9
Issue
20
Pages
3468-3476
ISSN
  • 1613-6810 (ISSN-L)
  • 1613-6829
OpenAlex
W2130172678
Cited by
60
References
21
Citations by year
2026: 1 · 2025: 3 · 2024: 1 · 2023: 1 · 2022: 4 · 2021: 5 · 2020: 7 · 2019: 4 · 2018: 4 · 2017: 5 · 2016: 8 · 2015: 8 · 2014: 9
FWCI
5.02
Type
journal article
Language
en
Open access
closed
Locations
  • Small (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Hydrogels: synthesis, properties, applications
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Microencapsulation and Drying Processes
Keywords
core-shell microcapsules, angiogenesis, growth factor delivery, PLGA, alginate, layer-by-layer assembly, chitosan, platelet-derived growth factor, vascular endothelial growth factor, controlled release, human umbilical vein endothelial cells, endothelial sprouting, biomaterials
MeSH terms
Polylactic Acid-Polyglycolic Acid Copolymer, Albumins, Alginates, Biocompatible Materials, Emulsions, Hexuronic Acids, Humans, Microspheres, Molecular Weight, Platelet-Derived Growth Factor, Polyglycolic Acid, Viscosity, Drug Delivery Systems, Neovascularization, Physiologic, Lactic Acid, Glucuronic Acid, Vascular Endothelial Growth Factor A, Human Umbilical Vein Endothelial Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review